(Q33704606)

28 July 2017

1 reference

title

Platelet PlA2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics (English)

1 reference

28 July 2017

1 reference

Goldschmidt-Clermont PJ

series ordinal

1

1 reference

28 July 2017

Roos CM

series ordinal

2

1 reference

28 July 2017

Cooke GE

series ordinal

3

1 reference

28 July 2017

publication date

1 August 1999

1 reference

Journal of Thrombosis and Thrombolysis

28 July 2017

published in

1 reference

28 July 2017

volume

8

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

89-103

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1008954916972

28 July 2017

exact match

0 references

cites work

Platelet GP IIIa PlA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke

1 reference

12 December 2020

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial.

1 reference

12 December 2020

Dynamic actin structures stabilized by profilin.

1 reference

12 December 2020

Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformers.

1 reference

12 December 2020

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

12 December 2020

A human beta-actin expression vector system directs high-level accumulation of antisense transcripts

1 reference

12 December 2020

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

1 reference

12 December 2020

Parental history is an independent risk factor for coronary artery disease: the Framingham Study

1 reference

12 December 2020

GPIIb/IIIa antagonists: pathophysiologic and therapeutic insights from studies of c7E3 Fab.

1 reference

12 December 2020

Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates

1 reference

12 December 2020

Platelet glycoprotein IIb/IIIa genetic polymorphism is associated with plasma fibrinogen levels in myocardial infarction patients. The REGICOR Investigators.

1 reference

12 December 2020

Family history of heart attack as an independent predictor of death due to cardiovascular disease

1 reference

12 December 2020

The relationship of reported parental history to the incidence of coronary heart disease in the Western Collaborative Group Study

1 reference

12 December 2020

Glycoprotein IIIa polymorphism and risk of myocardial infarction.

1 reference

12 December 2020

Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study

1 reference

12 December 2020

Modulation of the affinity of integrin alpha IIb beta 3 (GPIIb-IIIa) by the cytoplasmic domain of alpha IIb

1 reference

12 December 2020

Genetic susceptibility to death from coronary heart disease in a study of twins

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Lack of association between platelet glycoprotein IIb/IIIa receptor PlA polymorphism and coronary artery disease or carotid intima-media thickness

1 reference

12 December 2020

Population variability in the effect of aspirin on platelet function. Implications for clinical trials and therapy

1 reference

12 December 2020

A monoclonal antibody (SZ21) specific for platelet GPIIIa distinguishes P1A1 from P1A2.

1 reference

12 December 2020

Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes

1 reference

12 December 2020

A comparison of reteplase with alteplase for acute myocardial infarction

1 reference

12 December 2020

Acetylation of prostaglandin synthase by aspirin

1 reference

12 December 2020

Immediate coronary angiography in survivors of out-of-hospital cardiac arrest

1 reference

12 December 2020

HPA-1 genotype in arterial thrombosis--role of HPA-1b polymorphism in platelet function.

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

Genetic polymorphisms and risk of coronary artery disease

1 reference

12 December 2020

Predicting coronary heart disease in siblings--a multivariate assessment: the Framingham Heart Study

1 reference

12 December 2020

Gene frequencies of the five major human platelet antigens in African American, white, and Korean populations

1 reference

12 December 2020

Failure of aspirin treatment after stroke

1 reference

12 December 2020

PlA2 polymorphism and efficacy of aspirin

1 reference

12 December 2020

Binding of recombinant fibrinogen mutants to platelets

1 reference

12 December 2020

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

12 December 2020

A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

1 reference

12 December 2020

Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death

1 reference

12 December 2020

Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis

1 reference

12 December 2020

Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo

1 reference

12 December 2020

Role of platelet glycoprotein PLA1/A2 polymorphism in restenosis after percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

The efficacy and potency of antiplatelet activity of ticlopidine is increased by aspirin

1 reference

12 December 2020

Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: the Stroke Prevention in Young Women Study

1 reference

12 December 2020

Increased Platelet Aggregability Associated With Platelet GPIIIa Pl A2 Polymorphism

1 reference

12 December 2020

Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease.

1 reference

12 December 2020

The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein

1 reference

12 December 2020

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

12 December 2020

The relationship between smoking and triglyceride-rich lipoproteins is modulated by genetic variation in the glycoprotein IIIa gene

1 reference

12 December 2020

Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke

1 reference

12 December 2020

Coronary thrombosis in myocardial infarction. Report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction

1 reference

12 December 2020

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

1 reference

12 December 2020

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Coronary thrombosis and the platelet glycoprotein IIIA gene PLA2 polymorphism

1 reference

12 December 2020

Inherited platelet glycoprotein polymorphisms and a risk for coronary heart disease in young central Europeans

1 reference

12 December 2020

Development of aspirin resistance in persons with previous ischemic stroke.

1 reference

12 December 2020

A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris

1 reference

12 December 2020

Aspirin versus clopidogrel: the wrong question?

1 reference

12 December 2020

The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

1 reference

12 December 2020

Interaction of integrin alpha IIb beta 3 with multiple fibrinogen domains during platelet adhesion

1 reference

12 December 2020

Sequence 274-368 in the beta 3-subunit of the integrin alpha IIb beta 3 provides a ligand recognition and binding domain for the gamma-chain of fibrinogen that is independent of platelet activation

1 reference

12 December 2020

Platelet activation in unstable coronary disease

1 reference

12 December 2020

Clinical pharmacology of eptifibatide

1 reference

12 December 2020

Lack of relationship between the P1A1/P1A2 polymorphism of platelet glycoprotein IIIa and premature myocardial infarction

1 reference

12 December 2020

Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers

1 reference

12 December 2020

Prevalence of hypercholesterolemia among siblings of persons with premature coronary heart disease. Application of the Second Adult Treatment Panel guidelines.

1 reference

12 December 2020

The multiple risk factor intervention trial (MRFIT). A national study of primary prevention of coronary heart disease

1 reference

12 December 2020

PIa1/a2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty

1 reference

12 December 2020

PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis

1 reference

12 December 2020

Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trial

1 reference

12 December 2020

The unstable atherosclerotic plaque: clinical significance and therapeutic intervention

1 reference

12 December 2020

The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing

1 reference

12 December 2020

The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l'Infarctus du Myocarde

1 reference

12 December 2020

Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes

1 reference

12 December 2020

1 reference

12 December 2020

The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein

1 reference

12 December 2020

Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective

1 reference

12 December 2020

A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction

1 reference

12 December 2020

A monoclonal antibody to the human platelet glycoprotein IIb/IIIa complex induces platelet activation

1 reference

12 December 2020

Hyperhomocysteinemia and atherothrombotic disease

1 reference

12 December 2020

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

1 reference

12 December 2020

Mutational analysis of the ligand binding domain of the low density lipoprotein receptor

1 reference

12 December 2020

Effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. The RESTORE Investigators. Randomized Efficacy Study of Tiro

1 reference

12 December 2020

Cardiology. Attention shifts to the white clot

1 reference

12 December 2020

Polymorphisms of platelet glycoproteins in relation to macrovascular disease in type 2 diabetes mellitus

1 reference

12 December 2020

Effect of Ca2+ on GP IIb-IIIa interactions with integrilin: enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate

1 reference

12 December 2020

Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism

1 reference

12 December 2020

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

1 reference

12 December 2020

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

12 December 2020

Priming of platelet alphaIIbbeta3 by oxidants is associated with tyrosine phosphorylation of beta3

1 reference

12 December 2020

Thrombolysis in unstable angina

1 reference

12 December 2020

The genomic organization of platelet glycoprotein IIIa

1 reference

12 December 2020

Platelet hyperreactivity and prognosis in survivors of myocardial infarction

1 reference

12 December 2020

Polymorphism of platelet membrane glycoprotein IIIa: human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

Community-based interventions for sudden cardiac death. Impact, limitations, and changes

1 reference

12 December 2020

Chemical pathology of homocysteine. I. Atherogenesis

1 reference

12 December 2020

Clinical implications of coronary arteriographic findings soon after non-Q-wave acute myocardial infarction

1 reference

12 December 2020

Association of the platelet glycoprotein IIIa PlA1/A2 gene polymorphism to coronary artery disease but not to nonfatal myocardial infarction in low risk patients

1 reference

12 December 2020

Management of the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study after the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

The antiaggregating activity of clopidogrel is due to a metabolic activation by the hepatic cytochrome P450-1A

1 reference

12 December 2020

Lipoprotein(a) and the significance of the association between platelet glycoprotein IIIa polymorphisms and the risk of premature myocardial infarction.

1 reference

12 December 2020

Homocysteine and atherothrombosis

1 reference

12 December 2020

The antiplatelet effects of ticlopidine and clopidogrel

1 reference

12 December 2020

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

12 December 2020

Association of the platelet Pl(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease.

1 reference

12 December 2020

Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis

1 reference

12 December 2020

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

12 December 2020

Tissue factor modulates the thrombogenicity of human atherosclerotic plaques.

1 reference

12 December 2020

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Polymorphisms of human platelet membrane glycoproteins: structure and clinical significance

1 reference

12 December 2020

Mutation analysis in familial hypercholesterolemia patients of different ancestries: identification of three novel LDLR gene mutations.

1 reference

12 December 2020

Homocysteine and vascular disease

1 reference

12 December 2020

Polymorphism of the platelet glycoprotein IIIa gene in patients with coronary stenosis

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1008954916972

1 reference

Dimensions Publication ID

28 July 2017

1017696253

0 references

1 reference